Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

With Medicare coverage, a person can still have certain out-of-pocket costs for an inhaler. Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy ...

A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung diseases such as emphysema. The main cause is smoking, although the ...

Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper ...

Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. If you're new ...

We are building upon our strong heritage in bronchodilator and inhaler development with ongoing clinical development programmes aimed at improving the outlook for people with COPD. COPD is a ...

This results in an increased production of mucus leading to difficulty in breathing and extra production of phlegm (thhok). Emphysema develops when the alveoli, which are the air sacs in the lungs ...

BRIMICA GENUAIR 340/12 is a dry powder inhaler that uses your breath to deliver the medicine directly into your lungs. This makes it easier for chronic obstructive pulmonary disease (COPD ...